We are live on ! Find out more
PM

Penbrook Management Portfolio holdings

AUM $157M
1-Year Est. Return 46.57%
This Fund
S&P 500
This Quarter Est. Return
-14.31%
1 Year Est. Return
+46.57%
3 Year Est. Return
+102.93%
5 Year Est. Return
+150.44%
10 Year Est. Return
AUM
$127M
AUM Growth
-$27.3M
Cap. Flow
-$1.6M
Cap. Flow %
-1.26%
Top 10 Hldgs %
43.52%
Holding
112
New
3
Increased
9
Reduced
48
Closed
6

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$540K
2
CYBE
Cyberoptics Corp
CYBE
+$427K
3
OPRX icon
OptimizeRx
OPRX
+$399K
4
IDN icon
Intellicheck
IDN
+$371K
5
TWOU
2U Inc
TWOU
+$367K

Sector Composition

Rank Sector Weight
1 Healthcare 22.7%
2 Technology 22.57%
3 Energy 12.98%
4 Financials 10.58%
5 Industrials 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
76
Merck
MRK
$316B
$392K 0.31%
4,300
META icon
77
Meta Platforms (Facebook)
META
$1.5T
$387K 0.31%
2,400
KOPN icon
78
Kopin
KOPN
$693M
$359K 0.28%
320,950
-1,750
-0.5% -$2.63K
F icon
79
Ford
F
$57.5B
$338K 0.27%
30,375
MIN
80
Aberdeen Intermediate Income Fund
MIN
$274M
$337K 0.27%
113,429
TBIO
81
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$335K 0.26%
10,349
+2,340
+29% +$162K
DMLP icon
82
Dorchester Minerals
DMLP
$1.24B
$334K 0.26%
+14,000
New +$384K
EVT icon
83
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.13B
$323K 0.25%
13,539
-200
-1% -$5.07K
BTRS
84
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
$313K 0.25%
62,840
+1,350
+2% +$7.76K
ABNB icon
85
Airbnb
ABNB
$89.4B
$312K 0.25%
+3,500
New +$455K
ET icon
86
Energy Transfer Partners
ET
$69.8B
$306K 0.24%
30,618
+10,000
+49% +$112K
VKQ icon
87
Invesco Municipal Trust
VKQ
$537M
$305K 0.24%
30,000
WLY icon
88
John Wiley & Sons Class A
WLY
$2.7B
$291K 0.23%
6,100
COP icon
89
ConocoPhillips
COP
$145B
$280K 0.22%
3,120
-1,000
-24% -$103K
DBI icon
90
Designer Brands
DBI
$331M
$272K 0.21%
20,820
CVX icon
91
Chevron
CVX
$385B
$261K 0.21%
1,800
NUV icon
92
Nuveen Municipal Value Fund
NUV
$1.91B
$237K 0.19%
26,500
DIS icon
93
Walt Disney
DIS
$170B
$235K 0.19%
2,490
ARCC icon
94
Ares Capital
ARCC
$13.8B
$230K 0.18%
12,840
-100
-0.8% -$1.97K
ITCI
95
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$228K 0.18%
4,000
AFL icon
96
Aflac
AFL
$64.5B
$227K 0.18%
4,100
SBGI icon
97
Sinclair Inc
SBGI
$1B
$213K 0.17%
10,400
-500
-5% -$11.6K
MMX
98
DELISTED
Maverix Metals Inc. Common Shares
MMX
$195K 0.15%
45,000
JPS
99
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$189K 0.15%
26,000
HBIO icon
100
Harvard Bioscience
HBIO
$28.5M
$180K 0.14%
5,000

Similar funds

Penbrook Management's Q2 2022 Portfolio in Review

As of Q2 2022, Penbrook Management held 112 positions worth $127M, down 18% from $154M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Penbrook Management's Q2 2022 filing shows 3 new, 9 increased, 48 reduced and 6 closed positions. Its largest new stake was Edgio, Inc. Common Stock: 4,494 shares worth $415K. The largest sale was Microsoft, an estimated $540K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Technology and Energy.

  • Penbrook Management's largest Q2 2022 buy was Edgio, Inc. Common Stock: 4,494 shares worth $415K.
  • Penbrook Management added most to IBM in Q2 2022, an estimated $361K increase.
  • Penbrook Management's biggest Q2 2022 reduction was Microsoft, cutting an estimated $540K.
  • Penbrook Management fully exited OptimizeRx in Q2 2022, selling an estimated $399K.
  • Penbrook Management's ten largest holdings make up 44% of its $127M portfolio in Q2 2022.
  • Penbrook Management opened 3 new positions and closed 6 in Q2 2022.
  • Penbrook Management's portfolio value fell 18% quarter-over-quarter to $127M.

Based on Penbrook Management's 13F filing for Q2 2022, filed 29 Jul 2022.